1. National Comprehensive Cancer Network. Antiemesis version 2.2014: National Comprehensive Cancer Network; 2014. Available from: http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf . Accessed 19 June 2014.
2. Dupuis LL, Boodhan S, Holdsworth M, Robinson PD, Hain R, Portwine C, et al. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2013;60:1073–82.
3. Apotex Inc. Apo-Metoclop; Product Monograph. Weston; 2014.
4. Sandoz Canada Inc. Metoclopramide Hydrochloride Injection; Product Monograph. Boucherville; 2014.
5. Health Canada. Summary safety review—metoclopramide—abnormal involuntary movements of the body (extrapyramidal symptoms) in children 2015. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/metoclopramide-eng.php . Accessed 17 Aug 2015.